Literature DB >> 16544060

Staging of colon and rectal cancer: from endoscopy to molecular markers.

F L Greene1.   

Abstract

The primary management of colorectal cancer begins with preoperative diagnosis and the ability to stage the extent of the tumor burden clinically. Endoscopic approaches have been pivotal in this management strategy, and have given rise to endoscopic techniques allowing for primary resection and treatment of metastases. This advance has allowed for the continued development of pathologic staging as used in the tumor node metastasis (TNM) system. The next major milestone in the staging of large bowel cancer will be to blend current anatomic staging strategies with specific molecular markers that will refine subsets appropriate for targeted therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16544060     DOI: 10.1007/s00464-006-0005-8

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  19 in total

1.  Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer.

Authors:  K Yasuda; Y Adachi; N Shiraishi; K Yamaguchi; Y Hirabayashi; S Kitano
Journal:  Ann Surg Oncol       Date:  2001-05       Impact factor: 5.344

2.  The role of the peritoneal reflection in the prognosis of carcinoma of the rectum and sigmoid colon.

Authors:  J W KIRKLIN; M B DOCKERTY; J M WAUGH
Journal:  Surg Gynecol Obstet       Date:  1949-03

3.  A consideration of pathological factors influencing five year survival in radical resection of the large bowel and rectum for carcinoma.

Authors:  R K GILCHRIST; V C DAVID
Journal:  Ann Surg       Date:  1947-10       Impact factor: 12.969

4.  The prognostic inhomogeneity of colorectal carcinomas Stage III: a proposal for subdivision of Stage III.

Authors:  S Merkel; U Mansmann; T Papadopoulos; C Wittekind; W Hohenberger; P Hermanek
Journal:  Cancer       Date:  2001-12-01       Impact factor: 6.860

5.  Ultrastaging of colorectal cancer by sentinel lymph node mapping technique--a multicenter trial.

Authors:  S Saha; A Bilchik; D Wiese; M Espinosa; J Badin; B K Ganatra; D Desai; S Kaushal; T Singh; M Arora
Journal:  Ann Surg Oncol       Date:  2001-10       Impact factor: 5.344

6.  Molecular staging for survival prediction of colorectal cancer patients.

Authors:  Steven Eschrich; Ivana Yang; Greg Bloom; Ka Yin Kwong; David Boulware; Alan Cantor; Domenico Coppola; Mogens Kruhøffer; Lauri Aaltonen; Torben F Orntoft; John Quackenbush; Timothy J Yeatman
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

Review 7.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

8.  Sentinel node staging of resectable colon cancer: results of a multicenter study.

Authors:  Monica Bertagnolli; Brent Miedema; Mark Redston; Jeannette Dowell; Donna Niedzwiecki; James Fleshman; Jiri Bem; Robert Mayer; Michael Zinner; Carolyn Compton
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

9.  A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients.

Authors:  Frederick L Greene; Andrew K Stewart; H James Norton
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

Review 10.  The process for continuous improvement of the TNM classification.

Authors:  Mary K Gospodarowicz; Daniel Miller; Patti A Groome; Frederick L Greene; Pamela A Logan; Leslie H Sobin
Journal:  Cancer       Date:  2004-01-01       Impact factor: 6.860

View more
  5 in total

1.  Overexpression of matrix metalloproteinase 9 in tumor epithelial cells correlates with colorectal cancer metastasis.

Authors:  David S Zuzga; Ahmara Vivian Gibbons; Peng Li; Wilhelm Johannes Lubbe; Inna Chervoneva; Giovanni Mario Pitari
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

2.  Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis.

Authors:  Kathleen Lang; Jonathan R Korn; David W Lee; Lisa M Lines; Craig C Earle; Joseph Menzin
Journal:  BMC Cancer       Date:  2009-07-13       Impact factor: 4.430

3.  Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse.

Authors:  C-Y Lu; Y-H Uen; H-L Tsai; S-C Chuang; M-F Hou; D-C Wu; S-H Hank Juo; S-R Lin; J-Y Wang
Journal:  Br J Cancer       Date:  2011-02-22       Impact factor: 7.640

4.  Prognostic significance of Cytokeratin 20-positive lymph node vascular endothelial growth factor A mRNA and chromodomain helicase DNA binding protein 4 in pN0 colorectal cancer patients.

Authors:  Sze Chuen Cesar Wong; Moon Tong Cheung; Lewis Lai Yin Luk; Vivian Ha Man Lee; Pak Tat Chan; Hin Fung Andy Tsang; Evelyn Yin Kwan Wong; Vivian Weiwen Xue; Amanda Kit Ching Chan; John Kwok Cheung Chan
Journal:  Oncotarget       Date:  2017-12-19

5.  A study of lymph node ratio in stage IV colorectal cancer.

Authors:  Kristoffer Derwinger; Bengt Gustavsson
Journal:  World J Surg Oncol       Date:  2008-12-01       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.